Brigit Biofarmaka Teknologi Tbk. vs Tunas Alfin Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Tunas Alfin Tbk. trades at Rp610 (market cap 839.13B, 28.3K 24h volume). The key difference: Tunas Alfin Tbk. is far larger — about 4.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 28.3K). Which is the better fit depends on your goals.
| OBAT | TALF | |
|---|---|---|
Market Cap | 172.82B | 839.13B |
Volume | 592.2K | 28.3K |
Lot | 5.92K | 283 |
Turnover | 147.05M | 17.16M |
Average Price | 248.31 | 606.18 |
Value | 147.05M | 17.16M |
Indicative Equilibrium Price | 254 | 610 |
Indicative Equilibrium Volume | 10 | 46 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Tunas Alfin Tbk (the Company) was founded in 1977 and is based in Jakarta, Indonesia. With one of the largest production capacities, and some of the most advanced equipment and technologies in the region, the Company has also grown into one of the leading integrated fine and Fast Moving Consumer Goods (FMCG) packaging companies in Asia.The Company is currently capable of undertaking several coating processes such as Silicone, Hot Melt, Extrusion, Pressure/Self-Adhesive, Wax Coating and Anti-fungus Coating.
Read more on TALF →